» Articles » PMID: 25834543

Ganoderic Acid B's Influence Towards the Therapeutic Window of Trifluoperazine (TFP)

Overview
Journal Afr Health Sci
Date 2015 Apr 3
PMID 25834543
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Ganoderic acid B is an important bioactive ingredient isolated from Ganoderma lucidum, and exhibits various pharmacological activities.

Aims: To investigate the influence of Ganoderic acid B towards the therapeutic window of trifluoperazine (TFP).

Methods: In vitro human liver microsomes (HLMs) incubation system was used to determine the inhibition of Ganoderic acid B towards the glucuronidation of trifluoperazine (TFP).

Results: Ganoderic acid B exerted concentration-dependent inhibition towards the glucuronidation of TFP. Furthermore, Dixon plot was used to determine the inhibition type. The intersection point was located in the second quadrant in Dixon plot, indicating the competitive inhibition of Ganoderic acid B towards TFP glucuronidation. Through fitting the data using competitive nonlinear fitting equation, the inhibition kinetic parameter was calculated to be 56.7 uM.

Conclusion: All this data indicated the potential influence of Ganoderic acid B-containing herbs towards therapeutic window of TFP. Given that the glucuronidation reaction of TFP is the probe reaction of UGT1A4, the data obtained from the present study also indicated the potential influence of Ganoderic acid-containing herbs towards the therapeutic window of drugs mainly undergoing UGT1A4-mediated metabolism.

Citing Articles

From Ebola in the slums of East and West Africa to NCDs, mental, child and reproductive health.

Tumwine J Afr Health Sci. 2015; 15(1):i-iii.

PMID: 25834569 PMC: 4370150.

References
1.
King C, Rios G, Green M, Tephly T . UDP-glucuronosyltransferases. Curr Drug Metab. 2001; 1(2):143-61. DOI: 10.2174/1389200003339171. View

2.
Wang Z, Wong T, Hashizume T, Dickmann L, Scian M, Koszewski N . Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability. Endocrinology. 2014; 155(6):2052-63. PMC: 4020929. DOI: 10.1210/en.2013-2013. View

3.
Green M, Bishop W, Tephly T . Expressed human UGT1.4 protein catalyzes the formation of quaternary ammonium-linked glucuronides. Drug Metab Dispos. 1995; 23(3):299-302. View

4.
Uchaipichat V, Mackenzie P, Elliot D, Miners J . Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. Drug Metab Dispos. 2005; 34(3):449-56. DOI: 10.1124/dmd.105.007369. View

5.
Fang Z, Zhang Y, Ge G, Huo H, Liang S, Yang L . Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction. Br J Clin Pharmacol. 2010; 69(2):193-9. PMC: 2824481. DOI: 10.1111/j.1365-2125.2009.03572.x. View